indazoles has been researched along with plx 4720 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altelaar, AF; Cappadona, S; Greig, K; Heck, AJ; Maddalo, G; Peeper, DS; Possik, PA; Raaijmakers, LM; Smit, MA; van Breukelen, B | 1 |
1 other study(ies) available for indazoles and plx 4720
Article | Year |
---|---|
ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma.
Topics: Cell Line, Tumor; Chromatography, Liquid; Down-Regulation; Forkhead Transcription Factors; Humans; Indazoles; Indoles; Melanoma; Molecular Targeted Therapy; Mutation; Piperazines; Proteomics; Proto-Oncogene Proteins B-raf; Receptor, ErbB-3; rho-Associated Kinases; RNA Interference; RNA, Small Interfering; Sulfonamides; Tandem Mass Spectrometry; Vemurafenib | 2014 |